The Office for Life Sciences (OLS) is a joint unit between the Department of Health & Social Care (DHSC) and Department for Business, Energy & Industrial Strategy (BEIS).
This is a special bulletin to inform the life sciences sector that the MHRA has published detailed guidance on how medicines and medical devices will be regulated at the end of the Transition Period, in both a negotiated and non-negotiated outcome with the EU. This is to provide you with information from Government to help your members and networks prepare.
Published: 1st September 2020
Source: Office for Life Sciences, GOV UK
